Department of Clinical Laboratory, the affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, People's Republic of China.
Department of Clinical Laboratory, the affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, People's Republic of China.
Pathol Oncol Res. 2020 Oct;26(4):2621-2632. doi: 10.1007/s12253-020-00869-1. Epub 2020 Jul 6.
Due to the different mechanisms of cell-free DNA production, the single-stranded DNA to double-stranded DNA ratio in blood maybe different between healthy individuals and gastric cancer (GC) patients. We aimed to explore the potential application of this ratio in GC diagnosis. The plasma cell-free DNA extracts from 118 healthy individuals and 106 GC patients were prepared. The levels of single-stranded DNA or double-stranded DNA in plasma, and the single-stranded DNA to double-stranded DNA ratio on the diagnostic efficiency for GC were assessed with ROC curve. The relationships between this ratio and the clinical characteristics of GC patients were analyzed. The ratios in 63 GC patients before and after surgery were compared. In healthy individuals, the single-stranded DNA to double-stranded DNA ratio was not affected by factors including age, gender and BMI, and subjected to normal distribution (P = 0.1090). GC patients had a lower value of this ratio than healthy individuals (P < 0.0001). Considering this ratio as a GC diagnostic indicator, the area under ROC curve (AUC) was 0.923[95% confidence interval (CI):0.880-0.955]. This ratio in unresectable GC was obviously lower than that in resectable GC (P = 0.0045). There was a rank correlation between this ratio and GC TNM staging (rho = -0.266, P = 0.0058), but it had no correlation with tumor size (r = 0.14, P = 0.145). Additionally, this ratio was not affected by hemolysis and repeated freeze-thaw of blood samples, and was significantly elevated after surgery(P < 0.0001). The single-stranded DNA to double-stranded DNA ratio in plasma is a stable non-invasive indicator for GC diagnosis.
由于游离 DNA 产生的机制不同,健康个体和胃癌(GC)患者血液中的单链 DNA 与双链 DNA 比值可能不同。我们旨在探索该比值在 GC 诊断中的应用潜力。从 118 名健康个体和 106 名 GC 患者中提取血浆游离 DNA 进行分析。通过 ROC 曲线评估血浆中单链 DNA 或双链 DNA 水平以及单链 DNA 与双链 DNA 比值对 GC 的诊断效率。分析该比值与 GC 患者临床特征的关系,并比较 63 例 GC 患者手术前后的比值。在健康个体中,单链 DNA 与双链 DNA 比值不受年龄、性别和 BMI 等因素的影响,呈正态分布(P = 0.1090)。GC 患者的该比值低于健康个体(P < 0.0001)。将该比值作为 GC 诊断指标,ROC 曲线下面积(AUC)为 0.923[95%置信区间(CI):0.880-0.955]。不可切除 GC 的比值明显低于可切除 GC(P = 0.0045)。该比值与 GC TNM 分期呈秩相关(rho = -0.266,P = 0.0058),但与肿瘤大小无关(r = 0.14,P = 0.145)。此外,该比值不受溶血和血液样本反复冻融的影响,手术后明显升高(P < 0.0001)。血浆中单链 DNA 与双链 DNA 比值是一种稳定的非侵入性 GC 诊断指标。